WAPPS-Hemo is pleased to announce the launch of two new population pharmacokinetic (PK) models for ESPEROCT® (Antihemophilic Factor VIII (Recombinant, B-Domain Truncated), PEGylated) that use the one-stage and chromogenic assays.
Looking for an opportunity to participate in a clinical trial for WAPPS? There are currently two trials that are recruiting.
Currently available PK models in WAPPS-Hemo. New models are added when sufficient data has been collected.
Publications by the core WAPPS-Hemo team, the WAPPS-Hemo Research Network and other related publication sources.
myWAPPS Version 2.0 was just released with some exciting new features such as the Calendar View where you can enjoy a graphical view of your treatment log, an Export Function to export your infusion and note log, an Interactive Graph to see your level at any time in the future.
This new version sees the addition of Hungarian, Japanese and Russian.
WAPPS will take care of predicting the concentration at the time of the measurement you provide, based on the PK profile you intend to validate, using the appropriate dose and patient covariates.
At WAPPS-News we post the latest updates and changes to the WAPPS-Hemo program. Check back with us regularly. Contact us if you have any questions.
The WAPPS-HEMO Team
If you have any WAPPS-Hemo related research or news items you would like to share, please contact us
© 2024 Copyright WAPPS-Hemo